Examine publishes rigorous, unbiased analysis of the latest and most important nutrition and supplementation studies each month, available to all Examine Members. Click here to learn more or log in.
Study under review: WHO Guidelines: Risk reduction of cognitive decline and dementia
Other Articles in Issue #58 (August 2019)
-
Eating early in the day keeps glucose spikes at bay
In addition to helping with glycemic control, early time-restricted feeding may affect the expression of certain genes related to circadian rhythms and longevity, too.
-
Causally or corollary? An innovatively random approach to the TMAO question
Some research has supported the idea that trimethylamine N-oxide (TMAO, a metabolite of compounds found in animal products) is as scary as it sounds. But that research was mostly observational. This study investigated whether TMAO's link to metabolic disease is causal.
-
Under pressure: reducing salt intake to lower blood pressure
Does reducing salt intake actually reduce blood pressure? If so, by how much? This meta-analysis aimed to answer these questions.
-
Your brain on ketones: Does a ketogenic diet affect cognition, sleep, and mood?
Ketogenic diets affect nerves; that's why they're an effective treatment for some seizure disorders. But how these diets affect mood and cognition is less clear.
-
Interview: Lisa Lewis, EdD, CADC-II
In this interview with sports psychologist Lisa Lewis, we chat about some key takeaways from the field of sports psychology, behavioral addiction in sports, and more.
-
Low-calorie sweeteners: are they all created equal?
This clinical trial explored how four low-calories sweeteners affect bodyweight, body composition, and more.
-
Can some blueberries each day keep the doctor away?
How do freeze-dried blueberries affect the cardiometabolic health of people with the metabolic syndrome? This study aimed to find out.
